1.09
Jaguar Health Inc (JAGX) 最新ニュース
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - The Hutchinson News
Will Jaguar Health Inc. stock benefit from commodity prices2025 Sector Review & Risk Controlled Stock Alerts - ulpravda.ru
Will Jaguar Health Inc. (1JA0) stock extend growth story2025 Bull vs Bear & Weekly High Return Forecasts - ulpravda.ru
Why Jaguar Health Inc. stock remains on watchlistsBond Market & Weekly Setup with High ROI Potential - ulpravda.ru
Why Jaguar Health Inc. stock could see breakout soonJuly 2025 Intraday Action & Stepwise Swing Trade Plans - ulpravda.ru
Can Jaguar Health Inc. (1JA0) stock hold up in economic slowdownJuly 2025 Levels & Fast Moving Trade Plans - ulpravda.ru
Why hedge funds are buying Jaguar Health Inc. stockMarket Trend Report & High Accuracy Swing Entry Alerts - ulpravda.ru
Can Jaguar Health Inc. stock deliver sustainable ROEGDP Growth & Growth Focused Stock Pick Reports - ulpravda.ru
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - The Newark Advocate
Insider Sell: Is Jaguar Health Inc 1JA0 stock cheap vs fundamentalsTrade Risk Report & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Jaguar Health Reports Approval of All Proposals at August 2025 Annual Meeting of Stockholders - The Asheville Citizen Times
Jaguar Health reports PS reduction in pediatric intestinal failure study By Investing.com - Investing.com Australia
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication - ACCESS Newswire
Experimental drug lets some children rely less on IV nutrition support - Stock Titan
Knight Therapeutics and Jaguar Health Announce Strategic Partnership - ACCESS Newswire
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Ventura County Star
Jaguar Health (JAGX) Secures $240,000 FDA Grant for Canine Diarr - GuruFocus
FDA backs study of new treatment for chemo-related diarrhea in dogs - Stock Titan
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Norwich Bulletin
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID) - Montgomery Advertiser
Aug Big Picture: Why hedge funds are buying Jaguar Health Inc stock2025 Top Gainers & Community Supported Trade Ideas - moha.gov.vn
Jaguar Health (JAGX) Reports Promising Trials for Crofelemer in UAE - GuruFocus
Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 - Burlington Free Press
What analysts say about Jaguar Health Inc stockPrice Action Analysis & Free Stock Index Interpretations - earlytimes.in
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - Press & Sun-Bulletin
Sell Signal: Why Jaguar Health Inc 1JA0 stock benefits from AI revolution2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - moha.gov.vn
Aug PreEarnings: How Jaguar Health Inc. stock reacts to oil prices2025 Investor Takeaways & Target Return Focused Stock Picks - Улправда
Can Jaguar Health Inc. stock deliver surprise earnings beatJuly 2025 News Drivers & Momentum Based Trading Ideas - Улправда
Jaguar Health Earnings Notes - Trefis
How Jaguar Health Inc. stock reacts to oil prices2025 Market WrapUp & Stock Market Timing Techniques - Улправда
Why analysts recommend Jaguar Health Inc. (1JA0) stockJuly 2025 Retail & Real-Time Volume Analysis Alerts - DonanımHaber
Will Jaguar Health Inc. stock split attract more investorsQuarterly Market Summary & High Return Trade Opportunity Guides - DonanımHaber
Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Pensacola News Journal
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF) - Hornell Evening Tribune
Jaguar Health director gets 5,870 RSUs and 5,870 options | JAGX SEC FilingForm 4 - Stock Titan
大文字化:
|
ボリューム (24 時間):